Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 11/2008

01-11-2008 | Research Article

Metabolic Outcomes of Obese Diabetic Patients Following Laparoscopic Adjustable Gastric Banding

Authors: Rishi Singhal, Mark Kitchen, Sue Bridgwater, Paul Super

Published in: Obesity Surgery | Issue 11/2008

Login to get access

Abstract

Introduction

Obesity is an independent risk factor in the development of diabetes. Weight loss surgery is the most effective treatment of morbid obesity. This study examines the effect of gastric banding on metabolic profile in diabetics.

Methods

Between April 2003 and November 2007, 1,335 patients underwent laparoscopic adjustable gastric banding. Metabolic profile was examined on a subset of 254 patients. Of these, 122 were diabetic. Data collection included body mass index, weight, blood pressure, HbA1c, fasting glucose, total serum cholesterol, triglyceride, and medications taken for blood pressure and diabetes both preoperatively and 1 year postoperatively.

Results

Comorbid conditions in the diabetic patients included hypercholesterolemia (49.3%), hypertriglyceridemia (53.8%) and hypertension (92%). In 1 year, mean BMI reduced from 52.9 kg/m2 to 41.5 kg/m2. Of the patients, 93.1% experienced an improvement in fasting glucose levels and 75.4% patients an improvement in HbA1c levels at the end of 1 year. All patients experienced a decrease in insulin requirements, and 36.6% were able to totally discontinue using it. Of the patients, 100% showed improvement in their triglyceride level, and 90.9% showed improvement in their total cholesterol level. The mean arterial pressure improved in 87.5% of the patients.

Conclusion

The metabolic syndrome associated with morbid obesity is difficult to adequately control with medication. Laparoscopic gastric banding can be considered a potentially curative treatment option in the management of this syndrome.
Literature
1.
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523–9.PubMedCrossRef
2.
Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17(9):961–9.PubMedCrossRef
3.
Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241(19):2035–8.PubMedCrossRef
4.
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–65.
5.
Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281(21):2005–12.PubMedCrossRef
6.
Detournay B, Cros S, Charbonnel B, et al. Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab. 2000;26(5):363–9.PubMed
7.
Newburgh L. Control of hyperglycaemia of obese ‘diabetics’ by weight reduction. Ann Intern Med. 1942;17:935–42.
8.
Friedman MN, Sancetta AJ, Magovern GJ. The amelioration of diabetes mellitus following subtotal gastrectomy. Surg Gynecol Obstet. 1955;100(2):201–4.PubMed
9.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.PubMedCrossRef
10.
Pontiroli AE, Pizzocri P, Librenti MC, et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab. 2002;87(8):3555–61.PubMedCrossRef
11.
Pontiroli AE, Folli F, Paganelli M, et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care. 2005;28(11):2703–9.PubMedCrossRef
12.
Dixon JB, O’Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care. 2002;25(2):358–63.PubMedCrossRef
13.
14.
1983 Metropolitan Height and Weight Tables. New York: Metropolitan Life Foundation. Statistical Bulletin. 1983;64(1):2–9.
15.
16.
M Longmore IW, S Rajagopala. Oxford handbook of Clinical Medicine. 6 ed. 2004.
17.
Management of Hypertension in Adults in Primary Care: NICE, June 2006.
18.
Singhal R, Kitchen M, Ndirika S, Hunt K, Bridgwater S, Super P. The ‘Birmingham stitch’—avoiding slippage in laparoscopic gastric banding. Obes Surg. 2008 Apr;18(4):359–63. Epub 2008 Feb 20.PubMedCrossRef
19.
Ferchak CV, Meneghini LF. Obesity, bariatric surgery and type 2 diabetes–a systematic review. Diabetes Metab Res Rev. 2004;20(6):438–45.PubMedCrossRef
20.
Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 23 Jan 2008;299(3):316–23.PubMedCrossRef
21.
Spivak H, Hewitt MF, Onn A, Half EE. Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure. Am J Surg. 2005;189(1):27–32.PubMedCrossRef
22.
Ahroni JH, Montgomery KF, Watkins BM. Laparoscopic adjustable gastric banding: weight loss, co-morbidities, medication usage and quality of life at one year. Obes Surg. 2005;15(5):641–7.PubMedCrossRef
23.
Favretti F, Segato G, Ashton D, et al. Laparoscopic adjustable gastric banding in 1,791 consecutive obese patients: 12-year results. Obes Surg. 2007;17(2):168–75.PubMedCrossRef
24.
Myers JA, Sarker S, Shayani V. Treatment of massive super-obesity with laparoscopic adjustable gastric banding. Surg Obes Relat Dis. 2006;2(1):37–40; discussion 40.PubMedCrossRef
25.
Ballantyne GH, Farkas D, Laker S, Wasielewski A. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2006;16(9):1189–97.PubMedCrossRef
Metadata
Title
Metabolic Outcomes of Obese Diabetic Patients Following Laparoscopic Adjustable Gastric Banding
Authors
Rishi Singhal
Mark Kitchen
Sue Bridgwater
Paul Super
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 11/2008
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9500-4

Other articles of this Issue 11/2008

Obesity Surgery 11/2008 Go to the issue

Research Article

Glucose Levels and Insulin Secretion in Surgery-Induced Hyperglycemia in Normoglycemic Obese Patients

Research Article

Circumferential Abdominoplasty

Research Article

Impact of Morbid Obesity on Chewing Ability

Research Article

The Eradication of Helicobacter pylori is Affected by Body Mass Index (BMI)

Research Article

Different Effect of Laparoscopic Roux-en-Y Gastric Bypass and Open Biliopancreatic Diversion of Scopinaro on Serum PYY and Ghrelin Levels

Research Article

The Repair of Incisional Hernia Following Roux-en-Y Gastric Bypass—With or Without Concomitant Abdominoplasty?